Australia markets open in 3 hours 2 minutes
  • ALL ORDS

    7,779.60
    +0.90 (+0.01%)
     
  • AUD/USD

    0.7406
    +0.0024 (+0.32%)
     
  • ASX 200

    7,511.10
    +7.90 (+0.11%)
     
  • OIL

    69.16
    +1.01 (+1.48%)
     
  • GOLD

    1,806.50
    -8.00 (-0.44%)
     
  • BTC-AUD

    55,389.29
    +1,428.09 (+2.65%)
     
  • CMC Crypto 200

    1,005.54
    +29.64 (+3.04%)
     

Tune in, SPAC on, drop LSD

·1-min read

Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines.

For this week’s deep dive, Alex and Natasha and Danny decided that it was time to talk about drugs. No, not like drugs for fun, but instead drugs that you might have considered fun, but are now being redirected to help bolster your health.

Yep, that's our theme today. As it turns out, there are a number of startups and even nascently public companies that are pursing using drugs that we might consider recreational for serious health purposes. Which is neat, as our habit of decrying any drug that makes you feel better as immoral has likely held us back from learning quite a lot about them.

Frankly this was a fun one to record, even if the topic at hand is actually rather serious. Chat Friday morning!

Equity drops every Monday at 7:00 a.m. PST, Wednesday, and Friday at 6:00 a.m. PST, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts!

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting